Edition:
United Kingdom

Adrian Rawcliffe To Succeed James Noble As Adaptimmune Chief Executive Officer


Thursday, 27 Jun 2019 

June 27 (Reuters) - Adaptimmune Therapeutics PLC ::ADRIAN RAWCLIFFE TO SUCCEED JAMES NOBLE AS ADAPTIMMUNE CHIEF EXECUTIVE OFFICER.ADAPTIMMUNE THERAPEUTICS - TRANSITION TO OCCUR WHEN JAMES RETIRES FROM EXECUTIVE DUTIES, TRANSITIONS TO NON-EXECUTIVE DIRECTOR ROLE ON BOARD ON SEPT 1.ADAPTIMMUNE THERAPEUTICS PLC - COMPANY HAS STARTED A GLOBAL SEARCH FOR A NEW CFO, WHICH WILL BE SUBJECT OF A SEPARATE ANNOUNCEMENT..ADAPTIMMUNE THERAPEUTICS - ADRIAN RAWCLIFFE, CURRENTLY CHIEF FINANCIAL OFFICER OF COMPANY, WILL SUCCEED JAMES NOBLE AS CHIEF EXECUTIVE OFFICER. 

Company Quote

1.43
-0.01 -0.69%
23 Aug 2019